159
Participants
Start Date
November 30, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
IPX159
Placebo
Fieve Clinical Research, Inc., New York
Comprehensive Multiple Sclerosis Care Center, Patchogue
Sleep Lab of Northeastern Pennsylvania, Clarks Summit
Johns Hopkins Bayview Medical Center Campus, Baltimore
Raleigh Neurology Associates, P.A., Raleigh
Wake Research Associates, LLC, Raleigh
PMG Research of Wilmington, LLC, Wilmington
SleepMed of SC, Columbia
Coastal Carolina Research Center, Mt. Pleasant
NeuroTrials Research Inc, Atlanta
Georgia Health Sciences University, Augusta
SleepMed of Central Georgia, Macon
Neurology Associates of Ormond Beach, Ormond Beach
MD Clinical, Hallandale
PAB Clinical Research, Brandon
Resurgence Group, Palm Harbor
University of Alabama at Birmingham, Brimingham
University of Tennesee Health Science Center, Memphis
Kentucky Research Group, Louisville
Community Research, Crestview Hills
Community Research, Cincinnati
QUEST Research Institute, Farmington Hills
University of Iowa Hospitals and Clinics, Iowa City
Preferred Research Partners, Inc., Little Rock
Clinical Trial Network, Houston
Paragon Research Center, LLC, San Antonio
Future Research Trials of Neurology, Austin
Bhupesh Dihenia, M.D., P.A., Lubbock
Sleep-Alertness Disorder Center, Aurora
Neurological Research Institute, Santa Monica
Collaborative Neuroscience Network, Inc., Long Beach
Scripps Clinic, La Jolla
The Research Center of Southern California, Oceanside
Stanford Center for Human Sleep Research, Redwood City
Sleep Medicine Associates, Seattle
Sleep Health Centers, LLC, Brighton
Beacon Clinical Research, LLC, Brockton
Global Medical Institutes, LLC, Princeton
Lead Sponsor
Impax Laboratories, LLC
INDUSTRY